# Juhasz2022 - In silico evaluation of Paxlovid’s pharmacometrics for SARS-CoV-2

**Source**: [biomodels_ebi](https://www.ebi.ac.uk/biomodels/MODEL2402280001)
**Standard**: sbml
**Authors**: Ferenc A Bartha; Nóra Juhász; Sadegh Marzban; Renji Han; Gergely Röst

## Description

Paxlovid is a promising, orally bioavailable novel drug for SARS-CoV-2 with excellent safety profiles. Our main goal here is to explore the pharmacometric features of this new antiviral. To provide a 


## Usage

This model was auto-generated from the biomodels_ebi repository.

```yaml
# In a space.yaml wiring file:
models:
  - repo: Biosimulant/models
    alias: model
    manifest_path: models/epidemiology-sbml-juhasz2022-in-silico-evaluation-of-paxlovid-s-ph-model2402280001-model/model.yaml
```

## Tags

systemsbiology, sbml, biomodels_ebi, auto-generated, biomodels-ebi, non_curated
